Cargando…
Intravitreal Injection of Liposomes Loaded with a Histone Deacetylase Inhibitor Promotes Retinal Ganglion Cell Survival in a Mouse Model of Optic Nerve Crush
Various neuroprotective agents have been studied for the treatment of retinal ganglion cell (RGC) diseases, but issues concerning the side effects of systemically administered drugs and the short retention time of intravitreally injected drugs limit their clinical applications. The current study aim...
Autores principales: | Sung, Mi Sun, Moon, Myeong Ju, Thomas, Reju George, Kim, So Young, Lee, Jun Sung, Jeong, Yong Yeon, Park, In-Kyu, Park, Sang Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730870/ https://www.ncbi.nlm.nih.gov/pubmed/33291226 http://dx.doi.org/10.3390/ijms21239297 |
Ejemplares similares
-
Intravitreal injection of Huperzine A promotes retinal ganglion cells survival and axonal regeneration after optic nerve crush
por: Zhou, Lai-Yang, et al.
Publicado: (2023) -
Subtype-specific response of retinal ganglion cells to optic nerve crush
por: Daniel, S., et al.
Publicado: (2018) -
Effective Delivery of Exogenous Compounds to the Optic Nerve by Intravitreal Injection of Liposome
por: Lee, Junsung, et al.
Publicado: (2018) -
Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice
por: Li, Yan, et al.
Publicado: (2007) -
Valproate reduces retinal ganglion cell apoptosis in rats after optic nerve crush
por: Pan, Feng, et al.
Publicado: (2022)